American Thyroid Association Scientific Statement on the Use of Potassium Iodide Ingestion in a Nuclear Emergency

Angela M. Leung*, Andrew J. Bauer, Salvatore Benvenga, Alina V. Brenner, James V. Hennessey, James R. Hurley, Stacey A. Milan, Arthur B. Schneider, Krishnamurthi Sundaram, Daniel J. Toft

*Corresponding author for this work

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

This document serves to summarize the issues and the American Thyroid Association (ATA) position regarding the use of potassium iodide as a thyroid blocking agent in the event of a nuclear accident. The purpose is to provide a review and updated position statement regarding the advanced distribution, stockpiling, and availability of potassium iodide in the event of nuclear radiation emergencies in the United States.

Original languageEnglish (US)
Pages (from-to)865-877
Number of pages13
JournalThyroid
Volume27
Issue number7
DOIs
StatePublished - Jul 2017

Keywords

  • KI
  • nuclear emergency
  • nuclear power plant
  • potassium iodide
  • predistribution

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'American Thyroid Association Scientific Statement on the Use of Potassium Iodide Ingestion in a Nuclear Emergency'. Together they form a unique fingerprint.

  • Cite this

    Leung, A. M., Bauer, A. J., Benvenga, S., Brenner, A. V., Hennessey, J. V., Hurley, J. R., Milan, S. A., Schneider, A. B., Sundaram, K., & Toft, D. J. (2017). American Thyroid Association Scientific Statement on the Use of Potassium Iodide Ingestion in a Nuclear Emergency. Thyroid, 27(7), 865-877. https://doi.org/10.1089/thy.2017.0054